DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES
Canada
3060687
Filed on 2002-05-22
3060687
Filed on 2002-05-22
INTERGENIC SITES BETWEEN CONSERVED GENES IN THE GENOME OF MODIFIED VACCINIA ANKARA (MVA) VACCINIA VIRUS
US Application 16/579,276
Filed on 2019-09-23
Filed on 2019-09-23
Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation
US Application 16/498,572
Filed on 2019-09-27
Filed on 2019-09-27
ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION
US Patent 11,236,151
Filed on 2020-01-03
Filed on 2020-01-03
ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION
European Patent
18724410.8
Filed on 2018-04-25
18724410.8
Filed on 2018-04-25
Novel Multivalent Nanoparticle-Based Vaccines
Japan
2019-206110
Filed on 2015-12-31
2019-206110
Filed on 2015-12-31
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
Mexico
MX/a/2019/011888
Filed on 2018-04-04
MX/a/2019/011888
Filed on 2018-04-04
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
South Korea
10-2019-7032483
Filed on 2018-04-04
10-2019-7032483
Filed on 2018-04-04
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
Japan
2019-555006
Filed on 2018-04-04
2019-555006
Filed on 2018-04-04